ZEGA Investments’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358K Buy
32,066
+13,807
+76% +$168K 0.04% 218
2026
Q1
$255K Buy
+18,259
New +$256K 0.03% 244

Other funds holding BTAL

ZEGA Investments's BTAL Position: Q2 2026 in Review

ZEGA Investments increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 76% in Q2 2026, buying an estimated $168K and bringing the position to 32,066 shares worth $358K. The position accounts for 0.04% of the portfolio, ranked #218.

ZEGA Investments first reported a position in BTAL in Q1 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • ZEGA Investments held 32,066 shares of AGF US Market Neutral Anti-Beta Fund worth $358K as of Q2 2026.
  • ZEGA Investments bought 13,807 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $168K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.04% of ZEGA Investments's portfolio in Q2 2026, its #218 holding.
  • ZEGA Investments first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2026 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on ZEGA Investments's 13F filing for Q2 2026, filed 31 Jul 2026.